GlassScriptPhysician profile
Jessica Fultz
NPI 1114445897
$1,853.46
in general payments reported to CMS, 2019-2025
21 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $218 · 2022: $586 · 2023: $475 · 2024: $278 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,049.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,049.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $323.14 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $189.43 | 2022-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $170.40 | 2021-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $150.24 | 2021-2024 | Verquvo |
| Amgen INC. | $130.42 | 2022-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $126.60 | 2021-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $107.40 | 2021-2024 | Brilinta |
| Irhythm Technologies, INC. | $103.75 | 2022-2023 | Zio Xt Patch |
| Pfizer INC. | $98.66 | 2021-2025 | |
| Boston Scientific Corporation | $91.42 | 2024-2025 | Watchman Flx |
| Lantheus Medical Imaging, INC. | $61.25 | 2022-2024 | Definity |
| Kiniksa Pharmaceuticals, LTD. | $50.75 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.46 | 2022-2023 | Jardiance |
| Astellas Pharma US INC | $38.20 | 2021-2022 | |
| Esperion Therapeutics, INC. | $37.56 | 2024-2025 | Nexletol |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $32.16 | 2023 | (5091) Amb Mon & Diag Und |
| Lexicon Pharmaceuticals, INC. | $23.94 | 2023 | Inpefa |
| Abiomed | $23.68 | 2025 | |
| Novo Nordisk INC | $19.84 | 2024 | Wegovy |
| Abbott Laboratories | $19.62 | 2022 | |
| Sanofi-Aventis U.S. LLC | $14.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Fultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.